Atlas Trials

Clinical Pharmacology

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Clinical Pharmacology

RecordFirmDate
Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740 (NCT05437094)Cardurion Pharmaceuticals, Inc.2022-06-27
Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects (NCT04511611)Bayer2019-01-24
Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on the Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 15 mg in Japanese Healthy Male Adult Subjects (NCT04511637)Bayer2019-01-21
A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects (NCT03517943)Bayer2018-04-24
A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects (NCT03517930)Bayer2018-04-17
Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects (NCT02629562)Cinfa Biotech2015-11-01
Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet (NCT03074058)Bayer2015-06-10
TAK-114 Single- and Multiple-Dose Phase 1 Study (NCT02286518)Takeda2014-11-01
Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects (NCT02276274)Takeda2014-06-01
A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects (NCT02113020)Takeda2014-02-01
Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design. (NCT03136666)Bayer2010-04-19
Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and Weight (NCT04366622)Bayer2010-04-14
Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862 (NCT01473108)Bayer2010-03-29
Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight (NCT04364464)Bayer2010-02-19

Track Clinical Pharmacology automatically

Every clearance here is in the API, with alerts when new ones post.